Obstructive vs Restrictive Lung Disease: PFT Logic
Pulmonary · 8 min read · 2026-05-28
Introduction
Pulmonary function test questions look intimidating because they present a table of numbers, but the underlying logic is a short, repeatable decision tree. Once you know which three values to check and in what order, you can classify almost any PFT pattern within seconds: FEV1/FVC ratio to separate obstructive from restrictive disease, TLC to confirm the pattern, and DLCO to identify the underlying etiology.
Step 1: Check FEV1/FVC Ratio
This ratio is the first branch point.
- FEV1/FVC less than 0.7 (or below the lower limit of normal) indicates an obstructive pattern. Airflow out of the lungs is impaired, so FEV1 falls proportionally more than FVC.
- FEV1/FVC normal or increased suggests a restrictive pattern. Both FEV1 and FVC are reduced roughly proportionally, so the ratio stays preserved or even rises slightly.
Step 2: Confirm with TLC
TLC verifies the pattern suggested by the ratio.
- Obstructive disease: TLC is normal or increased due to air trapping and hyperinflation, most dramatic in emphysema.
- Restrictive disease: TLC is decreased, reflecting reduced lung volume from parenchymal, chest wall, or neuromuscular limitation.
Step 3: Use DLCO to Find the Etiology
DLCO measures gas transfer across the alveolar-capillary membrane and separates diseases within each category.
- Obstructive with low DLCO: emphysema, because alveolar wall destruction reduces surface area for gas exchange.
- Obstructive with normal or high DLCO: chronic bronchitis and asthma, because the airway problem does not damage the alveolar-capillary membrane.
- Restrictive with low DLCO: interstitial lung disease (pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis), because the parenchyma itself is diseased.
- Restrictive with normal or high DLCO: extrapulmonary causes such as obesity, kyphoscoliosis, and neuromuscular disease (myasthenia gravis, ALS, Guillain-Barre), because the lung parenchyma is structurally normal and the limitation is mechanical.
Worked Example 1
A 65-year-old smoker has FEV1/FVC of 0.55, TLC of 130% predicted, and DLCO markedly reduced. FEV1/FVC below 0.7 confirms obstruction. Elevated TLC confirms air trapping. Low DLCO points to emphysema rather than chronic bronchitis, since chronic bronchitis typically preserves DLCO.
Worked Example 2
A 50-year-old with progressive dyspnea and dry cough has FEV1/FVC of 0.85, TLC of 65% predicted, and DLCO reduced. The high-normal ratio with low TLC confirms a restrictive pattern. The reduced DLCO localizes the problem to the lung parenchyma, consistent with idiopathic pulmonary fibrosis rather than an extrapulmonary cause.
Worked Example 3
A 30-year-old with obesity and daytime hypersomnolence has FEV1/FVC of 0.82, TLC of 70% predicted, and DLCO normal. This is restrictive by ratio and TLC, but the normal DLCO indicates the parenchyma is intact, so the cause is extrapulmonary, most consistent with obesity-related chest wall restriction.
Comparison Table: PFT Pattern Summary
Common Pitfall
Students often stop after identifying obstructive vs restrictive and forget that DLCO is what separates high-yield diagnoses within each group. A restrictive pattern with normal DLCO is not lung disease at all and should redirect your differential toward chest wall or neuromuscular causes rather than interstitial lung disease.
Clinical Pearl
Asthma is unique among obstructive diseases because its FEV1/FVC ratio and FEV1 can normalize with bronchodilator administration, showing significant reversibility (typically greater than 12% and 200 mL improvement in FEV1). This reversibility is what distinguishes it from fixed obstruction in emphysema or chronic bronchitis on a PFT-based question.
Summary
Interpret every PFT stem with the same three-step sequence: FEV1/FVC ratio to classify obstructive versus restrictive, TLC to confirm lung volume changes, and DLCO to pinpoint the underlying etiology. This structured approach turns a dense numeric table into a fast, confident diagnosis and generalizes to nearly every pulmonary PFT vignette you will encounter on Step 1 and Step 2 CK.
Flow-Volume Loop Clues
Beyond the numeric values, the shape of the flow-volume loop offers another layer of diagnostic information that appears on more advanced questions.
- Obstructive disease produces a scooped-out or concave appearance on the expiratory limb, reflecting airway collapse during forced exhalation.
- Restrictive disease produces a narrow loop of reduced overall size but with a normal or even steeper shape, since airflow rates are preserved relative to the smaller lung volumes.
- Fixed upper airway obstruction (tracheal stenosis) flattens both the inspiratory and expiratory limbs, while variable extrathoracic obstruction (vocal cord paralysis) flattens mainly the inspiratory limb.
Residual Volume and Functional Residual Capacity
In obstructive disease, residual volume increases disproportionately due to air trapping, which is why TLC rises even when a patient is symptomatic and functionally limited. In restrictive disease, all lung volumes tend to fall together, including residual volume, functional residual capacity, and vital capacity, giving the globally reduced but proportionally shaped loop described above.
Distinguishing Neuromuscular from Parenchymal Restriction
A subtle but testable distinction within restrictive disease is neuromuscular weakness versus parenchymal fibrosis. Both reduce TLC and preserve or increase FEV1/FVC, but neuromuscular disease typically preserves DLCO (normal alveolar-capillary membrane) and often shows a significant drop in vital capacity when measured supine versus upright, reflecting diaphragmatic weakness. Fibrotic lung disease instead shows a primary reduction in DLCO regardless of position, along with crackles on exam and characteristic imaging findings such as honeycombing or ground-glass opacities.
Worked Example 4: Mixed Pattern
A 45-year-old with long-standing poorly controlled asthma and superimposed pulmonary fibrosis from chronic hypersensitivity pneumonitis exposure has FEV1/FVC of 0.65 and TLC of 95% predicted. Although the ratio suggests obstruction, the normal TLC (rather than increased) suggests a superimposed restrictive process is offsetting the expected hyperinflation. Mixed obstructive-restrictive disease should be suspected whenever the TLC does not match the direction predicted by the FEV1/FVC ratio alone, and DLCO combined with clinical history helps identify which process is contributing more to symptoms.
Bronchodilator Response and Diffusion Capacity Pitfalls
DLCO can also be falsely elevated in conditions unrelated to primary lung disease, including pulmonary hemorrhage (free hemoglobin avidly binds carbon monoxide) and polycythemia. Conversely, anemia can falsely lower DLCO independent of true gas exchange impairment, so many pulmonary function labs report a hemoglobin-corrected DLCO value. Recognizing these confounders prevents misclassifying a patient's underlying lung pathology based on DLCO alone without considering the clinical context.
Putting It Together on Test Day
When you encounter a PFT table, resist the temptation to scan all values at once. Follow the fixed sequence: ratio first, TLC second, DLCO third, and only then consider the clinical vignette details (smoking history, occupational exposure, autoimmune disease, neuromuscular symptoms) to select the single best diagnosis. This disciplined order prevents the common error of jumping to conclusions based on DLCO before confirming whether the fundamental defect is obstructive or restrictive in the first place.